Cargando…

Invariant natural killer T cells and incidence of first-time coronary events: a nested case-control study

AIMS: Invariant natural killer T (iNKT) cells, a T cell subset that is CD1d-restricted and expresses a semi-invariant T cell receptor, have been proposed to contribute to dyslipidaemia-driven cardiovascular disease due to their ability to specifically recognize lipid antigens. Studies in mice have a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomas, Lukas, Katra, Pernilla, Badn, Wiaam, Andersson, Linda, Nilsson, Jan, Schiopu, Alexandru, Engelbertsen, Daniel, Gonçalves, Isabel, Bengtsson, Eva, Björkbacka, Harry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630548/ https://www.ncbi.nlm.nih.gov/pubmed/38025652 http://dx.doi.org/10.1093/ehjopen/oead094

Ejemplares similares

Associations Between Macrophage Colony‐Stimulating Factor and Monocyte Chemotactic Protein 1 in Plasma and First‐Time Coronary Events: A Nested Case–Control Study
por: Schiopu, Alexandru, et al.
Publicado: (2016)

LAG3 Regulates T Cell Activation and Plaque Infiltration in Atherosclerotic Mice
por: Mulholland, Megan, et al.
Publicado: (2022)

Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
por: Jakobsson, Gabriel, et al.
Publicado: (2023)

CD163+ macrophages are associated with a vulnerable plaque phenotype in human carotid plaques
por: Bengtsson, Eva, et al.
Publicado: (2020)

Altered metabolism distinguishes high-risk from stable carotid atherosclerotic plaques
por: Tomas, Lukas, et al.
Publicado: (2018)

Activation of immune responses against the basement membrane component collagen type IV does not affect the development of atherosclerosis in ApoE-deficient mice
por: Vallejo, J., et al.
Publicado: (2019)

High levels of cathepsin D and cystatin B are associated with increased risk of coronary events
por: Gonçalves, Isabel, et al.
Publicado: (2016)

Plasma Levels of the Interleukin-1-Receptor Antagonist Are Lower in Women with Gestational Diabetes Mellitus and Are Particularly Associated with Postpartum Development of Type 2 Diabetes
por: Katra, Pernilla, et al.
Publicado: (2016)

Invariant Natural Killer T and Mucosal-Associated Invariant T Cells in Asthmatic Patients
por: Lezmi, Guillaume, et al.
Publicado: (2018)

Antitumor Responses of Invariant Natural Killer T Cells
por: Altman, Jennie B., et al.
Publicado: (2015)

Immunometabolic Activation of Invariant Natural Killer T Cells
por: Ververs, Francesca A., et al.
Publicado: (2018)

Antigen specificity of invariant natural killer T-cells
por: Birkholz, Alysia M., et al.
Publicado: (2015)

The two faces of invariant natural killer T cells
por: Walton, Emma L.
Publicado: (2015)

Metabolism in Invariant Natural Killer T Cells: An Overview
por: Yarosz, Emily L., et al.
Publicado: (2021)

Invariant natural killer T cells in lung diseases
por: Jeong, Dongjin, et al.
Publicado: (2023)

Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease
por: Mattisson, Ingrid Yao, et al.
Publicado: (2017)

Invariant NKT cells: Killers and conspirators against cancer
por: Bassiri, Hamid, et al.
Publicado: (2013)

Lineage Differentiation Program of Invariant Natural Killer T Cells
por: Kwon, Dong-il, et al.
Publicado: (2017)

Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity
por: Van Kaer, Luc, et al.
Publicado: (2018)

Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells
por: Garner, Lucy C., et al.
Publicado: (2018)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Bedard, Melissa, et al.
Publicado: (2017)

Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells
por: Popovic, Zoran V., et al.
Publicado: (2017)

Harnessing invariant natural killer T cells to control pathological inflammation
por: Bharadwaj, Nikhila S., et al.
Publicado: (2022)

Can Circulating Regulatory T Cells Predict Cardiovascular Disease?
por: Björkbacka, Harry
Publicado: (2016)

Finite-size corrections for nested Bethe ansatz models and conformal invariance
por: De Vega, H J
Publicado: (1987)

Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr (−/−) Mice Compared to Nondiabetic LDLr (−/−) Mice
por: Engelbertsen, Daniel, et al.
Publicado: (2012)

Modulatory Function of Invariant Natural Killer T Cells in Systemic Lupus Erythematosus
por: Chuang, Yi-Ping, et al.
Publicado: (2012)

Peripheral Blood Invariant Natural Killer T Cells of Pig-Tailed Macaques
por: Li, Xiangming, et al.
Publicado: (2012)

Activation and Regulation of B Cell Responses by Invariant Natural Killer T Cells
por: Doherty, Derek G., et al.
Publicado: (2018)

Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections
por: Trottein, François, et al.
Publicado: (2018)

Impact of Aging on the Phenotype of Invariant Natural Killer T Cells in Mouse Thymus
por: Papadogianni, Georgia, et al.
Publicado: (2020)

Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis
por: Pecher, Ann-Christin, et al.
Publicado: (2019)

Mitochondrial metabolism is essential for invariant natural killer T cell development and function
por: Weng, Xiufang, et al.
Publicado: (2021)

Dysregulated Peripheral Invariant Natural Killer T Cells in Plaque Psoriasis Patients
por: Hu, Yifan, et al.
Publicado: (2022)

Latent Mycobacterium tuberculosis Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells
por: Paquin-Proulx, Dominic, et al.
Publicado: (2018)

IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice
por: Mantani, Polyxeni T., et al.
Publicado: (2015)

High Levels of Soluble Lectinlike Oxidized Low‐Density Lipoprotein Receptor‐1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke
por: Markstad, Hanna, et al.
Publicado: (2019)

High Dimensionality Reduction and Immune Phenotyping of Natural Killer and Invariant Natural Killer Cells in Latent Tuberculosis-Diabetes Comorbidity
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2022)

Invariant Natural Killer T Cell Agonist Modulates Experimental Focal and Segmental Glomerulosclerosis
por: Pereira, Rafael L., et al.
Publicado: (2012)

Homeostatic Regulation of Marginal Zone B Cells by Invariant Natural Killer T Cells
por: Wen, Xiangshu, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4fa42h4da0u0ghd4ob8iro9ijb